WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.30) by 5.26 percent. This is a 31.91 percent increase over losses of $(0.47) per share from the same period last year. The company reported quarterly sales of $7.608 million which missed the analyst consensus estimate of $11.130 million by 31.64 percent. This is a 199.11 percent increase over sales of $(7.676 million) the same period last year.